APA Citatie

Nirvanappa, A. C., Mohan, C. D., Rangappa, S., Ananda, H., Sukhorukov, A. Y., Shanmugam, M. K., . . . Rangappa, K. S. (2016). Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. PLoS One.

Chicago Style citaat

Nirvanappa, Anilkumar C., et al. "Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PLoS One 2016.

MLA citatie

Nirvanappa, Anilkumar C., et al. "Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo." PLoS One 2016.